Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mihaela Stancu

Cardiovascular Disease Bloomington, IL Medical Doctor

NPI 1689877136 CMS profile 212723

1505 Eastland Dr, Suite 330, Bloomington, IL 61701

Open in the dashboard

General payments

$18,071

308 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mihaela Stancu of Bloomington, IL is reported in the CMS Open Payments database as having received $18,071 across 308 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,912 33
2024 General $3,044 48
2023 General $2,434 58
2022 General $3,000 57
2021 General $4,021 47
2020 General $504 22
2019 General $3,155 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mihaela Stancu
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Mihaela Stancu were reported at $1,912. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Mihaela Stancu Cardiovascular Disease median Middle half National median
2019 $3,155 $450 $127–$1,392 $163
2020 $504 $242 $77–$751 $114
2021 $4,021 $335 $101–$1,037 $132
2022 $3,000 $395 $121–$1,211 $149
2023 $2,434 $443 $136–$1,283 $160
2024 $3,044 $450 $136–$1,323 $164
2025 $1,912 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $6,669 115 payments
  2. Biotronik Inc. $4,500 24 payments
  3. Medtronic Vascular, Inc. $2,517 19 payments
  4. Medical Device Business Services, Inc. $1,136 5 payments
  5. Janssen Pharmaceuticals, Inc $1,087 45 payments
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $586 29 payments
  7. Novartis Pharmaceuticals Corporation $328 16 payments
  8. Biosense Webster, Inc. $248 4 payments
  9. E.R. Squibb & Sons, L.L.C. $236 13 payments
  10. Boston Scientific Corporation $151 5 payments
  11. Other $613 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,168 269 payments
  2. Travel and Lodging $8,903 39 payments
Products named General payments · program years 2019–2025
  1. Rivacor $2,502 9 payments
  2. Edora $2,502 9 payments
  3. Acticor $2,502 9 payments
  4. Solia $2,316 7 payments
  5. BioMonitor $2,316 7 payments
  6. Micra $1,394 17 payments
  7. Carto 3 $1,310 8 payments
  8. XARELTO $1,087 45 payments
  9. SelectSecure $616 19 payments
  10. Sentus $605 3 payments
  11. Other $6,002 174 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

776

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$171,745

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

24.5%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 45 $55,821
Entresto Sacubitril/Valsartan Brand 45 $46,336
Xarelto Rivaroxaban Brand 42 $41,284
Jardiance Empagliflozin Brand 15 $12,862
Farxiga Dapagliflozin Propanediol Brand 14 $7,525
Amiodarone Hcl Generic 55 $1,777
Metoprolol Succinate Generic 66 $1,421
Atorvastatin Calcium Generic 122 $1,030
Bumetanide Generic 14 $782
Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip Brand 14 $454

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$57,503

Medicare's payments for the services billed

Medicare patients

270

Average age 74

Services billed

768

152 women, 118 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 63%
Diabetes 54%
Atrial fibrillation 53%
Ischemic heart disease 48%
Arthritis 47%
Chronic kidney disease 46%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LEQVIO
  • Novartis Pharmaceuticals Corporation $69
$69 — —
VYNDAQEL
  • PFIZER INC. $64
$64 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $51
$51 15 —
ENTRESTO
  • Novartis Pharmaceuticals Corporation $24
$24 45 —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

308 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record